2023-05-09 08:42:56 ET
- uniQure press release ( NASDAQ: QURE ): Q1 GAAP EPS of -$1.63 misses by $0.73 .
- Revenue of $5.33M (+197.8% Y/Y).
- As of March 31, 2023, the Company had cash and cash equivalents and investment securities of $315.3 million.
- The Company expects cash and cash equivalents and investment securities will fund operations into 2025 assuming the achievement of $100.0 million of first commercial sale milestone in the United States, and into the first half of 2025 if the $75.0 million first commercial sale milestone for HEMGENIX ® in any of the five contractually defined European countries is achieved prior to July 2, 2023
For further details see:
uniQure GAAP EPS of -$1.63 misses by $0.73, revenue of $5.33M